Future Fertility

News

It's no secret that fertility treatment is expensive and has a low success rate, placing a big financial and emotional burden on would-be parents.

News

Pressure is building on Amgen to withdraw rare disease therapy Tavneos, after the CHMP recommended its marketing authorisation by revoked in the EU.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.